期刊文献+

黄曲霉毒素B1诱导的恶性转化肝细胞miRNA表达谱的变化 被引量:2

Differentially expressed miRNA profile of transformed hepatic cells induced by aflatoxin B1
下载PDF
导出
摘要 目的:检测黄曲霉毒素B1(aflatoxin B1,AFB1)诱导的恶性转化肝L02细胞(L02T)的miRNA表达谱,寻找差异表达的miRNA。方法:以含有AFB1的培养液多次间歇性染毒L02细胞获得转化细胞L02T,通过miRNA芯片技术检测和分析对照L02和转化L02T细胞的miRNA表达谱;用实时荧光定量PCR方法对芯片结果加以验证;采用TargetScan软件预测miRNA可能调控的靶基因。结果:获得2组细胞856个miRNA的表达谱,在25个表达差异显著的miRNA中,15个表达上调,10个表达下调;用定量RT-PCR对芯片结果中表达差异的miR-320a、miR-638和miR-98进行验证,并对其中上调显著的miR-638进行生物信息学分析,预测到4个与肝癌相关的潜在靶基因。结论:在AFB1诱导的恶性转化肝L02细胞中筛查出25个表达差异显著的miRNA,差异表达的miRNA可能在细胞恶性转化过程中起重要作用。 OBJECTIVE:To identify the differentially expressed miRNAs in malignantly transformed L02 cells(L02T) induced by aflatoxin B1(AFB1),we performed miRNA microarray on both control cells(L02) and L02T cells.METHODS:L02T cells were obtained after exposure to aflatoxin B1(AFB1) several times.The comparison of differential expression profiles between L02 and L02T cells was performed and analyzed.The differentially expressed miRNAs were then selected for validation by semi-quantitative real-time PCR.The targets of miRNAs were predicted by TargetScan program.RESULTS:856 human miRNAs were analyzed by miRNA microarray.25 differentially expressed miRNAs were found in L02T cells compared with L02 cells,with 15 upregulated and 10 downregulated.Among these miRNAs,miR-320a,miR-638 and miR-98 were vahdated by quantitative real-time PCR.Moreover,predicted by TargetScan program,we identified 4 genes that were potentially targeted by miR-638. These genes might be associated with hepatic cell transformation induced by AFB1.CONCLUSION:25 differentially expressed miRNAs were identified in AFB1—transformed L02T cells.These miRNAs may play important roles in the process of malignant transformation of human cells.
出处 《癌变.畸变.突变》 CAS CSCD 2011年第1期26-30,共5页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 国家自然科学基金项目(30800930) 国家杰出青年基金(30925029)
关键词 黄曲霉毒素B1 永生化人肝细胞 细胞恶性转化 MIRNA aflatoxin B1 immortalized human hepatic cells malignant cell transformation miRNA
  • 相关文献

参考文献22

  • 1Wang JS,Huang T,Su J,et al.Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village,Fusui County,People' s Republic of China[J].Cancer Epidemiol Biomarkers Prev,2001,10(2):143-146.
  • 2Esquela-Kerscher A,Slack FJ.Oncomirs-microRNAs with a role in cancer[J].Nat Rev Cancer,2006,6 (4):259-269.
  • 3Pang Y,Li W,Ma R,et al.Development of human cell models for assessing the carcinogenic potential of chemicals[J].Toxicol Appl Pharmacol,2008,232 (12):478-486.
  • 4He L,Hannon GJ.MicroRNAs:small RNAs with a big role in gene regulation[J].Nat Rev Genet,2004,5 (7):522-531.
  • 5Caldas C,Brenton JD.Sizing up miRNAs as cancer genes[J].Nat Med,2005,11(7):712-714.
  • 6Hebert C,Norris K,Scheper MA,et al.High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma[J].Mol Cancer,2007,6 (1):5.
  • 7Du L,Schageman JJ,Subauste MC,et al.miR-93,miR-98,and miR-197 regulate expression of tumor suppressor gene FUS1[J].Mol Cancer Res,2009,7 (8):1234-1243.
  • 8Mishra PJ,Song B,Mishra PJ,et al.MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism[J].PLoS One,2009,24,4 (12):e8445.
  • 9Cimmino A,Calin GA,Fabbri M,et al.miR-15 and miR-16 induce apoptosis by targeting BCL2[J].PNAS USA,2005,102 (9):13944-13949.
  • 10Chan JA,Krichevsky AM,Kosik KS.MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells[J].Cancer Res,2005,65 (7):6029-6033.

共引文献20

同被引文献73

  • 1朱惠莲,洪微,张作文.我国预防医学研究面临的机遇与挑战[J].生命科学,2006,18(1):4-8. 被引量:16
  • 2王菊,赵建军,马旭.丙烯酰胺对斑马鱼胚胎发育过程中microRNA表达的影响[J].毒理学杂志,2007,21(3):169-171. 被引量:8
  • 3Bota J, Chivalric RR, O'Donnell KA, et al. Therapeutic miRNA delivery suppresses tumorigenesis in a murine liver cancer model [J] Cell, 2009, 137(6): 1005 -1017.
  • 4Cornflour C, Factor VM, Andersen JB, et al. Loss of miRNA- 122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties [ J]. Onco- gene ,2009,28 (40) :3526 - 3536.
  • 5Foment F, Grampian L, Giannini C, et al. miRNA-122/eyclin G1 interaction modulates p53 activity and affects doxorubiein sen- sitivity of human adenocarcinomata cells[J]. Cancer Res, 2009, 69(14) : 5761 -5767.
  • 6Furuta M, Ozawkie KI, Kanaka S, et al. miRNA-124 and miR- NA-203 are epigenetically silenced tumor-suppressive Microfloras in hepatocellular carcinoma [ J ]. Carcinogenesis, 2010,31 (5) : 766 - 776.
  • 7Ivanovo I, Ball AS, Diag RL, et al. Microfloras in the miRNA- 106b family regulate p21/CDKN1A and promote cell cycle pro- gression [ J ]. Mol Cell Bio1,2010,28 ( 7 ) : 2167 - 2174.
  • 8Foment F, Lazzo M, Chico P, et al. miRNA-199a-3p regulates m Tot and c-Met to influence the doxorubicin sensitivity of human adenocarcinomata cells[ J]. Cancer Res,2010, 70(12) : 5184 - 5193.
  • 9An FF, Wang H, Chen YC, et al. Ahs-let-7g inhibits prolifera- tion of hepatocellular carcinoma Cells by down-regulation of c-Myc and up-regulation of p16(INK4A) [ J]. Int J Cancer, 2010,128 : 319 -331.
  • 10Li AM, Poon RT, Auk JM. miRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties [ J ]. Biochem Biophys Res Commun, 2010,394 (3) : 623 - 627.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部